← Leaderboards
Robin Jean Leach
University Of Texas Hlth Sci Ctr San Ant
$4,298,894
Attributed
$5,363,787
Total exposure
8
Grants
3
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.
Funding over time
peak $867.2K · FY2012–25$1M$750K$500K$250K$0
'12
'13
'14
'15
'16
'17
'18
'19
'20
'21
'22
'23
'24
'25
Funding mix
By agency
NIH$6,141,009 · 9
By mechanism
R01$2,651,053 · 3
P20$1,558,492 · 2
P30$1,041,894 · 2
U01$537,606 · 1
T32$351,964 · 1
Top collaborators
- Javier Hernandez3 shared
- Ian M Thompson3 shared
- Anna L Malkova2 shared
Most similar at University Of Texas Hlth Sci Ctr San Ant
Same institution · by research overlap
- Ian M Thompson$52,633,085
- Jennifer L Gibbs$1,365,852
- Susan L Naylor$2,130,610
Others in their field
Top investigators on “Malignant Neoplasms”
- David Heimbrook · Leidos Biomedical Research, Inc.$1,074,554,219
- Leonard Freedman · Leidos Biomedical Research, Inc.$527,106,485
- Ethan Dmitrovsky · Leidos Biomedical Research, Inc.$357,875,933
- Richard K. Wilson · Washington University$274,272,747
- Larry Arthur$223,443,122
- Lynn Briscoe · Leidos Biomedical Research, Inc.$186,892,879
Research focus
Malignant NeoplasmsResourcesTraining ProgramsAreaResearch PersonnelCancer CenterStudentsMinorityScientistProgramsS DegreeFacultyInstitutionAnticancer ResearchCommunitiesDoctor Of PhilosophyResource DevelopmentUndergraduate StudentMemberSkillsSouth TexasHealth SciencesNci Center For Cancer ResearchTexas
Grant awards (29)
Epigenetics, DNA repair and Genomics (EDGe) Training Program in Cancer$172,700
T32 · FY2025 · CA
Mays Cancer Center at UT Health SA$130,980
P30 · FY2025 · CA · contact PI
Epigenetics, DNA repair and Genomics (EDGe) Training Program in Cancer$179,264
T32 · FY2024 · CA
Mays Cancer Center at UT Health SA$131,376
P30 · FY2024 · CA · contact PI
Mays Cancer Center at UT Health SA$131,376
P30 · FY2023 · CA · contact PI
Mays Cancer Center at UT Health SA$131,376
P30 · FY2022 · CA · contact PI
Mays Cancer Center at UT Health SA$131,376
P30 · FY2021 · CA · contact PI
Mays Cancer Center at UT Health SA$131,306
P30 · FY2020 · CA · contact PI
San Antonio Center for Biomarkers of Risk for Prostate Cancer (SABOR)$100,000
U01 · FY2018 · CA · contact PI
San Antonio Center for Biomarkers of Risk for Prostate Cancer (SABOR)$337,606
U01 · FY2017 · CA · contact PI
San Antonio Center for Biomarkers of Risk for Prostate Cancer (SABOR)$100,000
U01 · FY2016 · CA
THE FEASIBILITY STUDIES FOR COLLABORATIVE INTERACTION FOR MINORITY INSTITUTE/CAN$192,706
P20 · FY2015 · CA · contact PI
The Cancer Bioinformatics Initiative: A UTSA/UTHSCSA Partnership (1 of 2)$188,658
P20 · FY2015 · CA · contact PI
Improving prostate biopsy efficiency: The finasteride challenge test$383,083
R01 · FY2014 · CA
The Cancer Bioinformatics Initiative: A UTSA/UTHSCSA Partnership (1 of 2)$186,123
P20 · FY2014 · CA · contact PI
THE FEASIBILITY STUDIES FOR COLLABORATIVE INTERACTION FOR MINORITY INSTITUTE/CAN$186,123
P20 · FY2014 · CA · contact PI
Improving prostate biopsy efficiency: The finasteride challenge test$413,631
R01 · FY2013 · CA
THE FEASIBILITY STUDIES FOR COLLABORATIVE INTERACTION FOR MINORITY INSTITUTE/CAN$190,610
P20 · FY2013 · CA · contact PI
The Cancer Bioinformatics Initiative: A UTSA/UTHSCSA Partnership (1 of 2)$190,610
P20 · FY2013 · CA · contact PI
Improving prostate biopsy efficiency: The finasteride challenge test$443,502
R01 · FY2012 · CA
THE FEASIBILITY STUDIES FOR COLLABORATIVE INTERACTION FOR MINORITY INSTITUTE/CAN$211,831
P20 · FY2012 · CA · contact PI
The Cancer Bioinformatics Initiative: A UTSA/UTHSCSA Partnership (1 of 2)$211,831
P20 · FY2012 · CA · contact PI
ELUCIDATION OF DYSMYELINATION IN THE 18Q-SYNDROME$251,985
R01 · FY2003 · NS
CORE--CYTOGENETICS AND GENETICS$254,104
P30 · FY2002 · CA
ELUCIDATION OF DYSMYELINATION IN THE 18Q-SYNDROME$251,985
R01 · FY2002 · NS
ELUCIDATION OF DYSMYELINATION IN THE 18Q-SYNDROME$251,985
R01 · FY2001 · NS
ISOLATION OF GENES FOR PAGET DISEASE AND OSTEOSARCOMA$205,573
R01 · FY2001 · AR
ELUCIDATION OF DYSMYELINATION IN THE 18Q-SYNDROME$249,671
R01 · FY2000 · NS
ISOLATION OF GENES FOR PAGET DISEASE AND OSTEOSARCOMA$199,638
R01 · FY2000 · AR